. Author manuscript; available in PMC: 2020 Apr 1.

Published in final edited form as: Pediatr Infect Dis J. 2019 Apr;38(4):406–409. doi: 10.1097/INF.0000000000002161

Table 3 -.

Clinical Data

	Overall n=993	RHD n=15 (1.5%)	No RHD n=978 (98.5%)	p-value
Clinical Data n=987^*
Receiving ART (n=986)	983 (99.7%)	15 (100.0%)	968 (99.7%)	0.032
Adherence to ART >80%^** (n=962)	878 (91.3%)	13 (87.7%)	865 (91.3%)	0.861
Receiving cotrimoxazole (n=984)	974 (99.0%)	14 (93.3%)	960 (99.9%)	0.367
Adherence to cotrimoxazole >80%^** (n=844) (RHD n=13)	721 (84.1%)	11 (84.6%)	710 (84.1%)	0.755
Most recent CD4 (cells/mm3) (n=917) (RHD n=14)	1140 (814.8–1508.5)	1090.5 (720–1474)	1142 (816.8–1513)	0.558
Most recent viral load (copies/mL)^*** (n=880) (RHD n=14)	0 (0–100)	0 (0–484)	0 (0–98)	0.672

6 subjects with missing demographic data (not available in EMR)

^**

Year average from most recent recorded clinic data

^***

If viral load assay was either “not detected” or <20 copies/mL, reported as 0